Now I have enough to give a thorough, clinically relevant answer tailored to this specific patient (Mrs. Yashodhamma, 63F, DM since 2016, presenting to GEF Eye Hospital). Let me synthesize everything from the PubMed review, the available lens menu, and clinical guidelines.
IOL Recommendation for Mrs. Yashodhamma — 63F, Diabetic, Phaco
Key clinical context from the prescription:
- Diabetes since 2016 (~10 years) — risk of diabetic retinopathy (DR) is significant
- Vision: RE 6/60, LE 5/60 — dense cataracts
- Self-pay patient
- Available lens options are from the GEF Eye Hospital price list you've shared
Biggest Concern in Diabetic Patients Choosing an IOL
Diabetes creates specific challenges that directly influence lens choice:
- Posterior capsular opacification (PCO) — higher rate than non-diabetics
- Risk of diabetic macular edema (DME) post-op — affects visual outcomes with premium lenses
- Anterior capsular phimosis and zonular weakness
- Hydrophilic acrylic IOLs → risk of calcification in eyes with proliferative DR or silicone oil
- Premium/multifocal IOLs require a healthy macula to deliver their benefit — DR compromises this
Recommended IOL Categories (Best to Acceptable) — Mapped to Available Options
✅ BEST CHOICE: Hydrophobic Monofocal IOL (Square-Edge)
Why: Square-edge hydrophobic acrylic IOLs are the gold standard in diabetics:
- Lowest PCO rate (square posterior edge inhibits lens epithelial cell migration)
- Hydrophobic material does not calcify (unlike hydrophilic in diabetics with DR)
- Allows unobstructed fundus monitoring for DR surveillance post-op
- Most cost-effective for diabetics with uncertain macular status
| Lens | Model | Price | Notes |
|---|
| Acrysof IQ | Foreign Alcon | ₹50,000 | ✅ Top pick — gold standard hydrophobic square-edge, excellent PCO prevention |
| Acrysof Single Piece | Foreign Alcon | ₹35,000 | ✅ Good budget option, same hydrophobic acrylic platform |
| Alcon Clareon/Magnificient/Technis Eyhance | Foreign Alcon | ₹70,000 | ✅ EDOF-monofocal hybrid; good if macula is intact |
Pros of hydrophobic monofocal:
- Lowest PCO
- No calcification risk
- Full fundus access for laser/anti-VEGF if DR progresses
- Predictable, stable refraction
Cons:
- Glasses needed for near/intermediate tasks
- Higher cost than Indian hydrophilic options
⚠️ USE WITH CAUTION: EDOF IOL (Extended Depth of Focus)
Technis Puresee / Clareon Vivity — ₹1,10,000
These are excellent lenses if macular function is confirmed intact (OCT macula normal, no DME, no significant DR).
Pros:
- Reduces spectacle dependence
- Better intermediate and some near vision
- Less dysphotopsia than multifocal
Cons:
- Expensive
- If DME develops post-op or DR worsens → patient loses the benefit of the premium price
- Halos/glare still possible
- Not ideal if retinopathy is moderate-severe
❌ AVOID: Multifocal IOLs (Panoptix, Tecnis Multifocal, Aurolab Multifocal)
Why avoid in this patient:
- Multifocal IOLs split light between distance and near focus — they require an excellent macula to work
- Diabetic retinopathy and macular edema will negate all benefit
- Halos, glare, and reduced contrast sensitivity are amplified
- Post-op anti-VEGF injections or laser photocoagulation are harder to perform
- If DR progresses → patient is stuck with an expensive lens that underperforms
❌ AVOID: Indian Hydrophilic IOLs (Aurovue/Acriol, Aurolab)
- Hydrophilic acrylic material has documented calcification risk in diabetics, especially with vitreous surgery, silicone oil, or proliferative DR
- Avoid unless budget is an absolute constraint
🔲 Toric IOLs — Only if Significant Corneal Astigmatism
If pre-op keratometry shows ≥1.25 D corneal astigmatism, consider:
- Technis Toric Monofocal (₹75,000) or Acryol-care Toric (₹49,500)
- Do NOT use toric multifocal in a diabetic unless macula is confirmed pristine
Summary Decision Tree for Mrs. Yashodhamma
Is there significant DR or DME?
├── Yes/Unknown → Hydrophobic Monofocal (Acrysof IQ ₹50,000)
└── No (OCT macula normal, mild/no DR)
├── Budget concern → Acrysof Single Piece (₹35,000)
├── Wants near independence → EDOF: Clareon Vivity/Technis Puresee (₹1,10,000)
└── Do NOT choose multifocal regardless
Top Pick Summary
| Priority | Lens | Price | Reason |
|---|
| 1st | Acrysof IQ (Foreign Alcon) | ₹50,000 | Best hydrophobic square-edge; gold standard for diabetics |
| 2nd | Acrysof Single Piece | ₹35,000 | Budget-friendly same platform |
| 3rd | Clareon Vivity / Technis Puresee (EDOF) | ₹1,10,000 | Only if OCT confirms normal macula + no DME |
Pre-op must-do before finalizing lens:
- OCT macula — check for DME or subclinical edema
- Fundus exam / FFA — grade DR severity
- Stabilize blood glucose pre-op (HbA1c ideally <8%)
- Biometry (IOLMaster) — already listed as ₹1,500 in their package
Source: Morya AK et al.
Intraocular lens selection in diabetic patients: How to increase the odds for success. World J Diabetes. 2024;15(6):1199.
PMID: 38983821